Feb 5, 2009 - Taro Pharmaceutical Industries Ltd. reported today that it has received final approval from the U.S. FDA for its Abbreviated New Drug Application for Lamotrigine Tablets (Chewable Dispersible), 5 mg and 25 mg.
The details can be read here.
No comments:
Post a Comment